Related Experiment Videos
[Visualization of tau isoforms by splicing-site specific antibodies]
1Department of Neuroscience, Osaka City University Medical School.
Rinsho Shinkeigaku = Clinical Neurology
|September 19, 2002
Summary
Researchers developed five specific tau antibodies to study tau lesions in Alzheimer's disease (AD) and other tauopathies. Findings reveal unequal tau isoform distribution in Alzheimer's neurofibrillary tangles (NFTs).
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Context:
- Alzheimer's disease (AD) is characterized by tau lesions, including neurofibrillary tangles (NFTs).
- Understanding the specific tau isoforms involved in NFT formation is crucial for disease mechanisms.
- Existing antibodies may lack the specificity to differentiate between the six human tau isoforms.
Purpose:
- To develop and characterize novel tau antibodies with high specificity for individual human tau isoforms.
- To investigate the differential expression and distribution of tau isoforms within NFTs in Alzheimer's disease and other tauopathies.
- To compare tau isoform composition in Alzheimer's NFTs with those found in other tauopathies.
Summary:
- Five novel tau antibodies were generated, targeting specific exon splicing sites or amino acid sequences of human tau isoforms.
- These antibodies demonstrated isoform-specific recognition of recombinant and hyperphosphorylated tau on Western blots.
- Immunohistochemical analysis revealed unequal abundance of tau isoforms in NFTs, with tau1-352 and tau1-381 being major species in Alzheimer's disease.
Impact:
- Provides a valuable toolset for precise investigation of tau isoform involvement in neurodegenerative diseases.
- Suggests distinct tau isoform selection mechanisms in Alzheimer's disease compared to other tauopathies.
- Opens new avenues for developing targeted diagnostics and therapeutics for tauopathies based on specific isoform profiles.